期刊文献+

氨甲环酸对玫瑰痤疮患者皮肤屏障功能和炎症反应的影响 被引量:19

The influence of tranexamic acid on skin barrier function and inflammation in rosacea
下载PDF
导出
摘要 目的:研究氨甲环酸对玫瑰痤疮患者皮肤屏障功能及炎症反应的影响。方法:对30例玫瑰痤疮患者采用自身左右脸对照的方法,治疗侧外用3%氨甲环酸溶液,对照侧外用基质溶液,每天2次。2周后评价双侧红斑程度、炎症性皮损数量及屏障相关生理指标[角质层含水量、经皮水分丢失(TEWL)、pH值1,并检测角质层完整性、角质层丝氨酸蛋白酶活性以及LL-37表达。结果:治疗侧较对照侧红斑程度轻,炎症性皮损数量显著减少(P<0.05);皮肤屏障相关生理指标、角质层完整性及乳酸刺激试验结果有显著改善,差异有统汁学意义(P<0.05);氨甲环酸还可以明显抑制角质层丝氨酸蛋白酶活性(P<0.05)和LL-37的表达。结论:外用氨甲环酸可通过抑制角质层丝氨酸蛋白酶活性及抗菌肽LL-37表达改善玫瑰痤疮患者受损的屏障功能,同时抑制炎症反应.可作为玫瑰痤疮治疗的辅助用药。 Objectives: To examine the influence of tranexamic acid on rosacea lesions and skin barrier function. Methods: Thirty patients with rosacea were included in the split-face study. 3% tranexamic acid solution was applied on one half of the face and matrix solution on the other side. After 2 weeks, the severity of erythema and number of inflammatory lesions were assessed. Skin barrier related indexes (water content in the stratum corneum, pH value and TEWL) were measured by non-in- vasive skin physiological test, and the integrity of the stratum corncum, serine protease activity and amount of LL-37 were tested. Results: Compare to the control side, the severity of crythema and the number of the inflammatory lesions of the test side reduced significantly (P 〈 0.05); skin barrier related indexes, the integrity of the stratum corneum and the result of the lactic test improved obviously (P〈 0.05); tranexamic acid can also inhibit the stratum corneum serine protease activity (P 〈 0.05) and the expression of LL-37. Conclusions: Tranexamic acid can inhibit serine protease activity and reduce the process- ing of LL-37 in stratum corneum, it can also improve the damaged skin barrier function in patients with rosacea. Clinically, it can also inhibit the inflammation. It may serve as an adjuvant therapy in rosacca.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2013年第6期345-347,共3页 Journal of Clinical Dermatology
基金 中国医师协会-资生堂DQ基金(CDA-OFF-11038) 北京市自然科学基金(7122181)资助项目
关键词 玫瑰痤疮 氨甲环酸 皮肤屏障功能 角质层蛋白酶活性 LL-37 rosacea, tranexamic acid, skin barrier function, stratum corneum protease activity, LL-37
  • 相关文献

参考文献11

  • 1Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea[J]. Nat Med, 2007, 13(8): 975-980.
  • 2Yamasaki K, Schauber J, Coda A, et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin[J]. FASEB J, 2006, 20(12): 2068-2080.
  • 3Hachem JP, Houben E, Crumrine D, et al. Serine protease sig- naling of epidermal permeability barrier homeostasis[J]. J Invest Dermatol, 2006, 126(9): 2074-2086.
  • 4Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea[J]. J Am Acad Der- matol, 2004, 50 (6): 907-912.
  • 5Elias PM, Hatano Y, Williams ML. Basis for the barrier abnor- mality in atopic dermatitis: outside-inside-outside pathogenic mechanisms[J]. J Allergy Clin Immunol, 2008, 121(6): 1337- 1343.
  • 6Elias PM, Arbiser J, Brown BE, et al. Epidermal vascular en- dothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psori- asis[J]. Am J Pathol, 2008, 173(3): 689-699.
  • 7Denda M, Kitamura K, Elias PM, et al. trans-4-(Aminomethyl) cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic a- gent, accelerates barrier recovery and prevents the epidermal hy- perplasia induced by epidermal injury in hairless mice and hu- mans[J]. J Invest Dermatol,1997, 109(1): 84-90.
  • 8Katsuta Y, Yoshida Y, Kawai E, et al. trans-4-(Aminomethyl)cy- clohexane carboxylic acid methylamide (t-AMCHA methylamide) inhibits the physical interaction between urokinase-type plas- minogen activator and stratum corneum, and accelerates the re- covery of barrier function[J]. J Dermatol Sci, 2005, 40(3): 218- 220.
  • 9Del RJ. Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vas- cular changes and facial erythema [J]. J Clin Aesthet Dermatol, 2012, 5(3): 16-25.
  • 10Choi KY, Chow LN, Mookherjee N. Cationic host defence pep- tides: muhifaceted role in immune modulation and inflammation [J]. J Innate Immun, 2012, 4(4): 361-370.

同被引文献159

  • 1王川颖.超脉冲二氧化碳点阵激光在中重度凹陷性痤疮瘢痕的疗效观察[J].中国医疗美容,2014,4(2):60-61. 被引量:17
  • 2黄淇敏,王敏怡.医疗服务中顾客满意度指标体系的建立及应用[J].上海第二医科大学学报,2005,25(10):1075-1078. 被引量:23
  • 3陈丽华.闪光灯-泵脉冲染料激光治疗酒渣鼻毛细血管扩张疗效观察[J].临床皮肤科杂志,2006,35(12):782-782. 被引量:5
  • 4Del Rosso JQ. Advances in understanding and managing msacea: part 1 : connecting the dots between pathophysiological mecha- nisms and common clinical features of rosa- cea with emphasis on vascular changes and facial erythema [ J ]. J Clin Aesthet Derma- tol,2012,5(3) :16 -25.
  • 5Yamasaki K, Gallo RL. The molecular pa- thology of rosacea [J]. J Dermatol Sci, 2009,55(2) :77 -81.
  • 6Meyer-Hoffert U, Schroder JM. Epidermal proteases in the pathogenesis of rosaeea [ J ]. J Invest Dermato1,2011,15 ( 1 ) : 16 - 23.
  • 7Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in msacea [ J]. Nat Med, 2007,13 ( 8 ) : 975 - 980.
  • 8Casas C,Paul C,Lahfa M,et al. Quantification of Demodex folliculommby PCR in msacea and its relationship to skin innate immune activation [J]. Exp Dermatol, 2012, 21 (12) :906 -910.
  • 9Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in Rosa- cea and stimulates enhanced serine prete- ase production by keratinocytes [ J]. J In- vest Dermatol, 2011,131 ( 3 ) :688 - 697.
  • 10Antal AS, Dombrowski Y, Koglin S, et al. Impact of vita rain D3 on cutaneous im- munity and antimicrebial peptide expres- sion [J]. Dermatoendocrinol, 2011, 3 (1) :18 -22.

引证文献19

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部